COMP <GO>
GRML vs CRDF // 10Y YIELD & FRED MACRO BETA
Greenland Mines Ltd. (NASDAQ) VS. Cardiff Oncology Inc. (NASDAQ) • 15-METRIC TALLY: GRML 2
— CRDF 1
■ METRIC PARITY
LAST: $4.58 (-10.89%) • MKT CAP: $70.3M
macro-sensitivity
—
LAST: $0.89 (-2.46%) • MKT CAP: $70.9M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GRML VS. CRDF)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GRML | CRDF | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -8.37% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -7.70% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -13.20% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 1/9 | +1.00 | GRML | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.0 | 38.9 | +0.10 | GRML | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $70.3M | $70.9M | -$603.5K | CRDF | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GRML REV | CRDF REV | GRML GROSS % | CRDF GROSS % | GRML FCF | CRDF FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $593.0K | — | — | -$5.9M | -$38.0M |
| FY 2024 | $0 | $683.0K | — | — | -$2.9M | -$37.8M |
| FY 2023 | $0 | $488.0K | — | — | -$446.9K | -$30.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GRML // BETA —
CRDF // BETA —